Nano-X Imaging Ltd. (NNOX)
| Market Cap | 34.41M -86.7% |
| Revenue (ttm) | 15.63M +31.5% |
| Net Income | -116.81M |
| EPS | -1.72 |
| Shares Out | 70.06M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 973,627 |
| Open | 0.5067 |
| Previous Close | 0.5107 |
| Day's Range | 0.4800 - 0.5100 |
| 52-Week Range | 0.4800 - 4.7050 |
| Beta | 1.26 |
| Analysts | Buy |
| Price Target | 4.13 (+740.97%) |
| Est. Earnings | Nov 19, 2026 |
About NNOX
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to ... [Read more]
Financial Performance
In 2025, Nano-X Imaging's revenue was $13.02 million, an increase of 15.40% compared to the previous year's $11.28 million. Losses were -$75.02 million, 40.2% more than in 2024.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for NNOX stock is "Buy." The 12-month stock price target is $4.13, which is an increase of 740.97% from the latest price.
News
Nanox Selected as One of TIME's Best Inventions of 2026 for its Nanox.ARC X
Nanox.ARC X recognized among the “world's most groundbreaking innovations” and for its approach to making advanced medical imaging more accessible
Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica
Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd.
Nano-X Imaging reports Q2 EPS (79c), consensus (12c)
Reports Q2 revenue $4.16M, consensus $5.39M. “To date there has been tangible progress in our commercialization strategy. We have expanded our U.S. distribution footprint to ten partners and begun pat...
Nano-X Imaging Earnings Call Transcript: Q2 2026
Revenue grew 37% year-over-year to $4.2 million, driven by Health IT and teleradiology growth, but a $40.7 million impairment led to a GAAP net loss of $55.5 million. Commercialization advanced with new installations, partnerships, and a CMS reimbursement code for AI solutions.
Nano-X Imaging Earnings release: Q2 2026
Nano-X Imaging released its Q2 2026 earnings on September 9, 2026, summarizing the period's financial results.
Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates
PETACH TIKVA, Israel, Sept. 09, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the...
Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England
Expands Nanox's growing U.S. distribution network with a leading New England-based medical imaging provider PETACH TIKVA, Israel — September 4 2026 — Nano-X Imaging Ltd. (“Nanox”, or the “Company”, NA...
Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026
PETACH TIKVA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will repo...
Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom
Initial three-year term includes minimum annual license commitments PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. (“ Nanox”, or the “Company” NASDAQ: NNOX), a leader in innovative medical...
Urgent Deadline for Shareholders who lost money in shares of Nano-X Imaging Ltd. (NASDAQ: NNOX)
Today, August 11, 2026, is the Lead Plaintiff Deadline NEW YORK, Aug. 11, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldesnstein"), a nationally recognized securities litig...
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2026 in Nano-X Imaging Ltd. Lawsuit - NNOX
Important Information Regarding Section 20(a) Individual Liability Claims Against Nano-X Imaging's CEO and CFO for Alleged $33.4 Million Q4 Net Loss NEW YORK, Aug. 6, 2026 /PRNewswire/ -- SueWallSt al...
Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
PETACH TIKVA, Israel, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nano-X Imaging Ltd. (Nasdaq: NNOX), (“Nano-X” or the “Company”) an innovative medical imaging technology company, today announced that it has en...
Nano-X Imaging Ltd. Stockholders Who Suffered Significant Losses Should Contact Robbins LLP Before the August 11 Lead Plaintiff Deadline for Information About Their Rights Against NNOX
SAN DIEGO, Aug. 5, 2026 /PRNewswire/ -- Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities who purchased or otherwise acquired Nano-X Ima...
Shareholders Sue Nano-X Over Chip Fabrication and Customer Demand Claims
A class action lawsuit was filed against medical imaging company Nano-X Imaging ($NNOX) on June 12, 2026. The federal securities lawsuit alleges that plaintiffs acquired Nano-X stock at artificially i...
NNOX Investors Have Rights – If You Lost Money Investing in Nano-X Imaging Ltd. Contact Robbins LLP for Information About Recovering Your Losses
SAN DIEGO, July 09, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Nano-X Imaging Ltd. (NASDAQ: ...
REMINDER: Nano-X Imaging Ltd. Investors With Significant Losses Must Act By August 11, 2026
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ:NNOX) investors of the August 11, 2026 deadline to seek the role of lead...
New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026
New SCCT abstracts from Brigham and Women's Hospital highlight the performance and clinical utility of Nanox.AI's FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its...
Nano-X Imaging downgraded to Neutral from Buy at Alliance Global
Alliance Global downgraded Nano-X Imaging (NNOX) to Neutral from Buy with a price target of $3, down from $5, to reflect lower visibility into the revenue outlook after the company…
NNOX INVESTOR REMINDER: Nano-X Imaging Ltd. Investors Have Until August 11, 2026 To Seek Lead Plaintiff Role
NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ:NNOX) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at inve...
Nano-X Imaging Earnings Call Transcript: Q1 2026
Revenue grew to $4.3M in Q1 2026, driven by teleradiology and Health IT, but cash burn and commercialization delays led to withdrawal of annual revenue guidance. Multiple new partnerships and restructuring efforts are underway, with a focus on operational milestones and cost control.
Nano-X Imaging Earnings release: Q1 2026
Nano-X Imaging released its Q1 2026 earnings on June 25, 2026, summarizing the period's financial results.
Nano-X Imaging reports Q1 EPS (20c), consensus (14c)
Reports Q1 revenue $4.31M, consensus $4.54M. “To date, we are beginning to see revenue and increased scan utilization from the Nanox.ARC,” said Erez Meltzer, CEO and acting chairman. “We’ve altered…
Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates
PETACH TIKVA, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class - NNOX
New York, New York--(Newsfile Corp. - June 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nano-X Imaging Ltd. (NASDAQ: NNOX) between March 31, ...
Law Offices of Frank R. Cruz Encourages Nano-X Imaging Ltd.
LOS ANGELES--(BUSINESS WIRE)---- $STOCKS--Law Offices of Frank R. Cruz Encourages Nano-X Imaging Ltd. (NNOX) Shareholders To Inquire About Securities Fraud Class Action.